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Background: The antibiotic resistance of pathogenic microorganisms is a worldwide problem. Each year several
million people across the world acquire infections with bacteria that are antibiotic-resistant, which is costly in terms
of human health. New antibiotics are extremely needed to overcome the current resistance problem.
Results: Transgenic flax plants overproducing compounds from phenylpropanoid pathway accumulate phenolic
derivatives of potential antioxidative, and thus, antimicrobial activity. Alkali hydrolyzed seedcake extract containing
coumaric acid, ferulic acid, caffeic acid, and lignan in high quantities was used as an assayed against pathogenic
bacteria (commonly used model organisms and clinical strains). It was shown that the extract components had
antibacterial activity, which might be useful as a prophylactic against bacterial infection. Bacteria topoisomerase II
(gyrase) inhibition and genomic DNA disintegration are suggested to be the main reason for rendering antibacterial
action.
Conclusions: The data obtained strongly suggest that the seedcake extract preparation is a suitable candidate for
antimicrobial action with a broad spectrum and partial selectivity. Such preparation can be applied in cases where
there is a risk of multibacterial infection and excellent answer on global increase in multidrug resistance in
pathogenic bacteria.
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The worldwide increase in the occurrence of multidrug re-
sistance (MDR) in bacterial pathogens has become a ser-
ious problem in the clinical treatment of infections [1].
We are witnessing a high increase in the resistance levels
of pathogenic bacteria and a sharp decrease in the efficacy
of conventional antibacterial therapy, often across the
whole spectrum of known therapeutics [2-4]. Even chemo-
therapeutics that are used as the last line of defense is less
effective in an eradication of infections involving MDR
strains. Bacteria can develop or acquire new mechanisms
of resistance and share the information by horizontal
transfer between species. Nowadays, over 90% of staphylo-
cocci, pneumococci and enterococci isolated from severe
infections are resistant to antibiotics. Increasing prevalence* Correspondence: mzuk@ibmb.uni.wroc.pl
1Faculty of Biotechnology, Wrocław University, Przybyszewskiego 63/77,
51-148 Wroclaw, Poland
3Linum Fundation, Stabłowicka 147/149, 54-066 Wrocław, Poland
Full list of author information is available at the end of the article
© 2014 Zuk et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.of methicillin-resistant Staphylococcus aureus (MRSA),
β-lactam- and macrolide-resistant pneumococci, and
glycopeptide- and vancomycin-resistant enterococci have
been reported [5]. Among the Gram-negative bacteria, the
most serious treatment problems are caused by MDR
Pseudomonas aeruginosa strains producing carbapene-
mases and MDR Enterobacteriaceae strains including
Escherichia coli and Klebsiella pneumoniae, which pro-
duce extended beta-lactamases (ESBL) [6]. In the WHO
(Word Health Organisation) report from World Health
Day 2011 Antimicrobial resistance: no action today, no
cure tomorrow, it was indicated that 150,000 people die
each year as a result of only one very dangerous disease,
multidrug-resistant tuberculosis (MDR-TB) [7]. The global
increase in multidrug resistance in pathogenic bacteria has
led to an increasing need for topical antimicrobial prod-
ucts that can be applied in cases of multibacterial infec-
tion. Many of the available agents have highly bactericidal
activity, but their cytotoxicity can also interfere with hu-
man tissues [8]. Actually one of the great challenges of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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agents that can be simultaneously effective as an unselect-
ive antibiotic and not indicate cytotoxic effect to human
cells. Such preparations will be useful in the case of multi-
bacterial and fungal infections.
Bioactive components isolated from plants are one al-
ternative to commercially available traditional antibiotic.
The rich source of bioactive metabolites may be flax
(Linum usitatissimum L.), an annual plant that grows
widely in the Mediterranean and temperate climate
zones. It is not only a source of oil and fibers but also
seedcake, the remains of the flax seeds after oil extrac-
tion. Seedcake has important dietary properties, and it is
also used against many diseases, such as skin, respiratory
tract and gastrointestinal tract diseases [9-11].
The health-promoting properties of flax can be further
improved by genetic modification.
Findings presented in this paper indicated extensive
spectrum antibacterial activity of preparation based on
flax seedcake. The material for that set of experiments
was derived from transgenic flax plants designated
W92. They were obtained by plant transformation
using the genes coding chalcone synthase (CHS), chal-
cone isomerase (CHI) and dihydroflavonol reductase
(DFR), which all control the synthesis of antioxidative
compounds generated via the phenylpropanoid path-
way [12].
Significant increases in the amounts of various flavo-
noids (kaempferol, quercetin) were reported in the
seeds of transgenic W92 flax. The levels of anthocya-
nins, proanthocyanidins and phenolic acids were also
higher in the W92 flaxseeds than those of the control
plants [13]. Ferulic, caffeic and p-coumaric acids and
their glucoside derivatives were the most common
phenolic acids present. Three main compounds from
the phenylpropanoid pathway were identified in the fi-
bers from W92 plants: vanillin, 4-hydrobenzoic acid
and acetovanillone. UPLC analysis of fibers from W92
flax also revealed the presence of ferulic acid. The same
compounds but in significantly lower amounts and dif-
ferent proportion between individual metabolites will
be found in unmodified plants. Therefore, for further
experiments on clinic bacterial stains, we used seedcake
from W92 transgenic flax.
Detailed analysis of seedcake extract from transgenic
flax indicates that such preparation is effective as an
antibiotic wide spectrum of bactericidal activity, useful
in the case of multibacterial and fungal infections is the
main goal of this study. The data obtained strongly sug-
gest that the seedcake extract a suitable candidate for
antimicrobial action with a broad spectrum and partial
selectivity. It is believed that this is the first report de-
scribing the potential of a product from GM flax for
antimicrobial application.Methods
Plant material
All of the presented experiments were performed on flax
plants (Linum usitatissimum L.). Seeds from unmodified
flax (cv. Linola) were obtained from the Flax and Hemp
Collection of the Institute of Natural Fibers, Poland.
Transgenic plants overproducing phenylpropanoid com-
pounds were previously generated in laboratories of the
University of Wroclaw [12] In brief, to construct the trans-
genic plants, we used a binary vector containing three
cDNAs from Petunia hybrida encoding chalcone synthase
[CHS, EMBL/GenBank database acc. no. X04080], chal-
cone isomerase [CHI, EMBL/GenBank database acc. no.
X14589] and dihydroflavonol reductase [DFR, EMBL/
GenBank database acc. no. X15537] in the sense orienta-
tion, under the control of the 35S promoter and OCS ter-
minator. The vector was introduced into Agrobacterium
tumefaciens and used for flax (cv. Linola) transformation.
The transgenic plants were preselected via PCR using
primers specific for the kanamycin resistance gene (npt II).
The relevant selection of transgenic plants was performed
by Northern blot analysis using radiolabeled cDNAs of all
three transgenes (CHS, CHI, and DFR) as probes. The de-
tails on plant transformation, selection and transgenic
plant analysis were described previously [12,14]. The
reference specimens were collected in the University of
Wroclaw Biotechnology Department in the form of tis-
sue culture plants and seeds from all of the cultivation
seasons.
In this study, we used the fifth generation transgenic
plants W92 (transgenic line W92.40) and unmodified
flax plants cv. Linola (as a control), both were field-
grown in the 2011 growing season. The 600 m2 was
seeded (sow density 600seeds/m2) and 12 kg of seeds,
15 kg stalks and finally 4,5 kg fiber for W92 as well as
control plants were obtained. The seeds were harvested
4 months after sowing and used for oil pressing. The
stems of plants were then retted by the dew method as
described previously [15]. Briefly, the harvested plant
stalks were spread evenly in field for at least 40 days.
Combined action of water (dew), sun and naturally oc-
curring in a soil bacteria and fungi caused degradation
of the cell-wall polysaccharides and middle lamella, re-
leasing the fibers from the stems. The retted stalks,
called straw, were dried in open air and were stored for
a short period (one week) to allow curing to occur, facili-
tating fibre removal. Final separation of the fibre is ac-
complished by a breaking process in which the brittle
woody portion of the straw is broken, which removes
the broken woody pieces (shaves) by beating or scraping.
Seedcake preparation
Flaxseeds (10 kg) were ground and transferred to an indus-
trial warm gear oil press (Oil PressDD85G – IBGMonoforts
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40°C. After the cold pressing, 5 to 7% of the total fatty acids
that are present in untreated seeds normally remain in the
seedcakes as a residual oil fraction. In order to remove
all of the fat from the seedcakes, the ground material
(~100 μm grain) was defatted by threefold extraction with
hot (65°C) hexane, after such treatment obtain 7.6 kg fully
defatted seedcakes. Afterward, the seedcakes were dried
and used for further analysis and for the preparation of the
alkali hydrolyzed seedcake extract.Determination of total phenolic content
The plant material (seeds, seedcakes and fibers) was
crushed using a laboratory mill. The seeds and seedcakes
were defatted using hot hexane before analysis. A 250-
mg sample of each material was extracted three times
with 800 μl of methanol containing 1% formic acid, and
sonicated for 15 min. Next, the samples were centrifuged
(10 min at 14000 g) and the clear supernatant was used
for the analysis. The total phenolics content was deter-
mined by the optimized Folin-Ciocalteau method [16],
referring to the calibration curve of gallic acid, which is
a phenol compound used as a standard. A total of 100 μl
of each sample solution was mixed with 0.2 ml of
Folin-Ciocalteau reagent, 2 ml of H2O, and 1 ml of 15%
Na2CO3. The absorbance was measured with a model
spectrophotometer at 765 nm after 2 hours incubation
at room temperature. The total phenolics were esti-
mated as gallic acid equivalent. The data were obtained
from the average of three determinations.
Determination of total anthocyanin content via the pH-
differential method [17] Samples of the ground and de-
fatted seeds, seedcakes (15 mg) and fibers (15 mg) were
extracted with 1 ml of methanol/HCl (95:5, v/v) in an
ultrasonic bath for 30 min. The extract was centrifuged at
14000 g for 10 min. Two dilutions of the sample were per-
formed: first, 100 μl of the supernatant was mixed with
900 μl of 0.025 M potassium chloride buffer, pH 1.0, and
then 100 μl of supernatant was mixed with 900 μl of
0.4 M sodium acetate buffer, pH 4.5. The solution was
allowed to stand at room temperature for 15 min, and
then the absorbance at 520 nm and 700 nm was mea-
sured, which allowed for haze correction. The results were
reported as cyanidin-3-O-glucoside equivalents.Evaluation of proanthocyanin content
For the measurements, 15 mg samples of defatted seeds
and seedcakes were used. Proanthocyanins were hydro-
lyzed with 1 ml of n-butanol/HCl (95:5, v/v) and 33 μl of
2% (w/v) NH4Fe(SO4)2 12H2O in 2 M HCl for 40 min at
95°C. The extract was centrifuged at 14000 g for 10 min,
and the supernatant was used for proanthocyanin content
evaluation. Proanthocyanin detection was carried out bymeasuring absorption at 540 nm, and proanthocyanin
content was expressed as catechin equivalents [18].
Measurement of phenolic acid and secoisolariciresinol
diglucoside (SDG) contents
A 250 mg sample of defatted flax seeds or seedcakes was
extracted three times with 1.5 ml of 80% methanol (v/v)
for 10 min at 80°C. Prior to extraction, the seedcakes were
finally defatted, again with hot hexane. The extracts were
centrifuged and evaporated to near dryness at 40°C under
a vacuum. The extract was then resuspended and sub-
jected to alkaline hydrolysis (1 ml, 0.3 M aqueous sodium
hydroxide) for 2 days at room temperature followed by
neutralization using 2 M HCl to pH= 6.0. The extract (3×
1-3 μl injection) was analyzed on a Waters Acquity UPLC
(Ultra Performance Liquid Chromatography) system with
a 2996 PDA detector, using Acquity UPLC column BEH
C18, 2.1100 mm, 1.7 μm. The mobile phase was A =
acetonitrile and B = 20 mM ammonium formate, pH 3.0
in a gradient flow: 1 min, 10% A/90% B; 2–6 min gradient
to 40% A/60% B, and 7 min gradient from 40% to100% A
with a 0.4 ml/min flow rate [19]. Measurements were
taken at 280 (SDG) and 320 nm (phenolic acids).
Extraction of phenylpropanoids from fibers
One gram of W92 flax fibers was ground in a Retch mill
to a fine powder (100 μm grain) and extracted three
times with10ml methanol. Extracts were pooled, evapo-
rated under a vacuum and resuspended in 2 ml metha-
nol. The remaining matter was hydrolyzed in 2 N NaOH
at room temperature for 24 hours in order to release
bound phenolics. Extracts were adjusted to pH 3.0 ex-
tracted three times with ethyl acetate, pH3.0 and then
the extract was evaporated under a vacuum and resus-
pended in 2 ml of methanol.
UPLC analysis of phenolics in flax fibers
The components were analyzed using the Acquity UPLC
system (Waters) equipped with an automated sample
injector and PDA detector. A 10-μl sample was applied
to an Acquity UPLC HSS- T3 column, 2.1 × 100 mm,
1.8 μm retaining better hydrophilic components. The
mobile phase was passed through the column at a flow
rate of 0.5 ml/min. The mobile phase consisted of 0.1%
formic acid (A) and 100% methanol (B). For the first
2 min, isocratic elution was carried out using 100% of A,
2–5 min a linear gradient to 30% A/70% B, 5–5.5 min to
0% A/100% n B. In the final minute (5,5-6,5 min) the
concentration of A was returned to 100%. An additional
analysis of the very hydrophilic component was per-
formed using a UPLC HILIC, 2.1 × 100 mm, 1.7 μm col-
umn. The mobile phase was passed through the column
at a flow rate of 0.4 ml/min. The mobile phase consisted
of 0.1% formic acid (A) and 100% acetonitrile (B). For
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gradient to 90% A/10% B. was applied, 8 - 9 min the gra-
dient to 100% A was used. In the final minute, the con-
centration of eluting solvents was returned to 10% A
/90% B [13].
Preparation of alkali hydrolyzed seedcake extract
Preparation was performed according modified method
previously described by Zuk et al. [13] Defatted flax seed-
cakes (100 g) were extracted three times with 400 ml of
80% methanol (v/v) for 15 min at 80°C. The extract was
centrifuged, the pellet was discarded and methanol from
the supernatant fraction was evaporated at 40°C. The
aqueous fraction of the extract was subjected to alkaline
hydrolysis in a final concentration of 0.3 M sodium hy-
droxide for 2 days at room temperature. The hydrolyzed
syrup was acidified with 2 M hydrochloric acid to pH 6.0.
The solution was cooled down to 10°C then centrifuged
with a high-speed centrifuge at 7000 rpm for 15 min to
precipitate and remove water-soluble polysaccharides and
proteins. After freeze-drying, the dry material was pre-
served at 4°C and used to prepare active water solutions
(w/v) of 50, 30 and10mg/ml. The solutions were sterilized
by filtration through an Acrodisc 0.22 μm filter (Gelman
Sciences, Ann Arbor, MI).
Antioxidant capacity measurement via
chemiluminescence method
The different seedcake extract solutions (from control
and GM plants) or active seedcake preparation at a con-
centration of 9.5 mg/ml, which is the equivalent of
10 mM gallic acid in the total phenolic measurement,
and a 10-mM solution of standard substances (ascorbic
acid, chlorogenic acid, caffeic acid, SDG) were diluted in
the range of 1000–15000 times with water, and directly
analyzed according to the published method [20].This
experiment was performed in a final volume of 250 μl
on white microplates in a solution containing 0.1 M
Tris–HCl buffer, pH 9.0, and 4 mM 2,2-azobis (2-Table 1 Content of phenylpropanoid compounds in three pre
and 50 mg/ml) dissolved in water
Compounds Compounds content
in dried extract (mg/gDW)
Secoisolariciresinol diglucoside (SDG) 548.41 ± 9.56
Ferulic acid 16.09 ± 0.63
Ferulic acid glucoside 29.55 ± 0.31
p-coumaric acid 4.94 ± 0.12
Coumaric acid glucoside 23.83 ± 0.62
Caffeic acid 0.32 ± 0.001
Caffeic acid glucoside 38.18 ± 0.51
The results are the mean values ± SD (n = 6).amidinopropane) dihydrochloride (AAPH), freshly pre-
pared. The luminol solution (100 mM) and diluted ex-
tract were automatically injected. The photons produced
in the reaction were counted on an EG&G Berthold
LB96P microplate luminometer at 30°C. The antioxidant
potential (IC50) was defined as the amount of flax ex-
tract (mg FW) that inhibits luminol chemiluminescence
by 50%.
Bacterial strains
Thirty-six Gram-negative clinical strains (Pseudomonas
aeruginosa [n = 16], Klebsiella pneumoniae [n = 10] and
Escherichia coli [n = 10]) and 15 Gram-positive clinical
strains (Staphylococcus aureus [n = 5], Staphylococcus
epidermidis [n = 5] and Enterococcus faecalis [n = 5])
were used to determine the antibacterial activity of seed-
cake extract. The tested strains were isolated from clinical
samples from patients hospitalized in the Lower Silesian
Centre of Pediatrics in Wroclaw, Poland. MDR isolates
were included in the selection (Additional file 1: Table S1
and Table S2). As references, we used the strains P. aerugi-
nosa ATCC 27853, K.pneumoniae ATCC 700603, E. coli
ATCC 25922, E.coli ATCC 11229, S. aureus ATCC 29213
and S. aureus ATCC 6538 from the American Type Cul-
ture Collection (LGC Standards, Lomianki, Poland). The
bacteria were stored at −70°C in Trypticase Soy Broth
(Becton Dickinson and Company, Cockeysville, MD, USA)
supplemented with 20% glycerol.
Determination of bacterial susceptibility
The antimicrobial activity of the seedcake extract was
measured by determining the minimum inhibitory con-
centration (MIC). The MIC tests were performed by a
broth microdilution method according to the European
Committee on Antimicrobial Susceptibility Testing stan-
dards (EUCAST, www.eucast.org). Three different dilu-
tions of W92 flax seedcake extract were prepared: 50, 30
and 10 mg/ml (for details see Table 1). The proper con-
centration of seedcake extract was prepared by mixingparations of W92 seedcake extract (10 mg/ml,30 mg/ml
Preparations compounds content in:
50 mgDW/ml 30 mgDW/ml 10 mgDW/ml
27.4 ± 0.03 16.0 ± 0.02 5.5 ± 0.02
0.803 ± 0.00 0.459 ± 0.04 0.178 ± 0.00
1.476 ± 0.01 0.866 ± 0.10 0.302 ± 0.02
0.254 ± 0.01 0.143 ± 0.02 0.049 ± 0.00
1.185 ± 0.00 0.743 ± 0.04 0.238 ± 0.01
0.016 ± 0.00 0.008 ± 0.00 0.003 ± 0.00
1.883 ± 0.02 1.093 ± 0.02 0.378 ± 0.01
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Dickinson and Company, Cockeysville, USA) and steril-
ized by filtration. The gentamicin (GM) and ampicillin
(AM) for antibiotic susceptibility tests were obtained from
Sigma-Aldrich Chemie GmbH (Steinheim, Germany). The
serial concentration of antibiotics were prepared in MHB
according to EUCAST standards [21]. For the experi-
ments, bacterial strains were inoculated onto blood agar
plates, incubated for 18 hours at 35°C, dissolved in PBS to
an optical density equal to McFarland No. 0.5 and then
diluted 1:10 (to approximate concentration 107 cells/ml).
10 μl samples of bacterial culture were added to a 96 mi-
crotitre plate containing 200 μl of the extract solution in
MHB/ antibiotic solution in MHB. The final concentration
of microorganisms was 5×105cfu/ml. The plates were then
incubated for 18 hours at 35°C. The MIC was defined as
the lowest concentration of seedcake extract at which no
visible growth of bacteria was observed after 18 hours in-
cubation. Positive controls (growth) consisted of bacteria
in broth. Negative controls (sterility) consisted of uninocu-
lated broth with which each of the extract dilutions was
performed. Each assay was performed in triplicate and re-
peated three times on a different day to ensure reproduci-
bility of the results.
Dynamics of microbial growth in the presence of
seedcake extract
In vitro killing curves were determined in the presence
of 10, 30 and 50 mg/ml seedcake extracts for the refer-
ence strains P. aeruginosa ATCC 27853, K. pneumoniae
ATCC 700603, E. coli ATCC 11229 and S. aureus ATCC
6538. The control consisted of bacteria in MHB alone.
The proper concentration of seedcake extract was pre-
pared by mixing with MHB and sterilized by filtration. For
the experiments, bacterial strains were inoculated onto
blood agar plates, incubated for 18 hours at 35°C, dis-
solved in PBS to an optical density equal to McFarland
No. 0.5 and then diluted 1:10 (to approximate concentra-
tion 107 cells/ml). 50 μl samples of bacterial culture were
added to eppendorf tube containing 1000 μl of the extract
solution in MHB. Samples of 10 μl were collected after 0,
2, 4, 8 and 24 hours of incubation, serially diluted and
plated on Mueller Hinton II Agar (BioMerieux, France).
The bacterial count (cfu/ml) was determined after 18 hours
of incubation at 35°C. Each assay was performed in
triplicate.
The inhibitory effect of standard substances on
bacterial growth
For the experiments, S. aureus ATCC 6538 was inocu-
lated onto blood agar plates, incubated for 18 hours at
35°C, and then diluted in PBS to an optical density equal
to McFarland No. 0.5. A 10-μl sample of bacterial cul-
ture was diluted 1:10 (approximate concentration: 107cells/ml) and added to the 96 microtitre plate containing
the commercially available standard substances solution
(ferulic acid, coumaric acid, caffeic acid, SDG) and seed-
cake extract in MHB. The final concentration of mi-
croorganisms was 5×105 cfu/ml. The plates were then
incubated for 6 hours at 35°C. The growth inhibition ef-
fect (% of inhibition in relation to untreated bacteria)
was calculated after 6hoursof incubation by measuring
the OD600. Each assay was performed in triplicate.
The inhibitory effect of seedcake extract on bacteria
gyrase activity
Reaction mixture (total volume 30 μl) consisted of 5× buf-
fer for enzyme (NEB), sterile deionized water, gyrase from
E.coli (NEB), substrate for gyrase (NEB) and particular
amount of seedcake extract (to the final concentration
10 mg/ml; 30 mg/ml; 50 mg/ml and 75 mg/ml of dried
extract respectively). Covalently closed substrate (pUC )
in a relaxed DNA form was used. As negative control
reaction mixture without gyrase or extract was used. As
total inhibition control reaction mixture with novobio-
cin and without extract was used. Samples were incu-
bated for 30 minutes at 37°C. Electrophoresis was run
in 1×TBE for 2 hours in 0.8% agarose gel without eth-
idium bromide.
Pulse-field gel electrophoresis of E.coli DNA upon
seedcake extract treatment
Bacteria cells (108 CFU/ml) incubated 1 hours with
seedcake extract were centrifuged, pellet was resus-
pended in 200 μl PBS, embedded in 2% low melting
agarose, then were treated first with lysozyme (10 μg/ml,
40 min at 30°C) and thereafter overnight with proteinase
K (50 μg/ml at 56°C). Agarose plugs were washed 3 times
with TE buffer and subjected to pulse-field electrophoresis.
Gel was run in 0.5% TBE, t1 = 1 s, t2 = 50s with included
angle 120°, at 12°C for 16.5 hours. After electrophoresis gel
was stained with ethidium bromide and analysed under
UV light (Gel Doc Imaging System, UVP Analitic).
Skin irritation test
An in vitro skin irritation test was performed according
to the MTT Effective Time-50 (ET-50) protocol de-
veloped at MatTek Corporation with the use of the Epi-
Derm skin irritation test. This test allows the valuation
of skin irritation due to cosmetic ingredients and ready-
made products. 100 μl of three preparations of seedcake
extracts (10 mg/ml, 30 mg/ml, 50 mg/ml) were put on
the surface of the epidermis model. As a positive control
(substance elicid skin irritation) the 1% Triton X-100
was used. After an incubation period of 2, 5 or 18 h, cell
viability was assessed using the MTT colorimetric test.
50 μL of MTT stock solution (4 mg/mL) was added to
each well to give a total reaction volume of 550 μL. After
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removed from the plate. The formazan crystals in each
well were dissolved in 500 μL of DMSO and incubated
for 30 min with gentle shaking. The absorbance at
540 nm was read on an Asys UVM340 Microplate
Reader (Biochrom, UK). The results were presented in%
as a reference to the control (100%). Skin irritation poten-
tial is predicted if the remaining relative cell viability is
below 50%. The experiment was performed in duplicate.Statistical analysis
Pearson correlation quotient was calculated. The cor-
relations were considered significantly significant at
p < 0,05. All statistical calculations were performed using
STATISTICA 7.1 software package (StatSoftPolska,
Poland).Results
Transgenic W92 flax (line W92.40) was previously ob-
tained by simultaneous overexpression of three genes en-
coding key enzymes of flavonoid biosynthesis (CHS, CHI
and DFR) under the control of the 35S promoter. Since
the constitutive promoter was used for the modification,
changes in compound contents were expected in the
whole plant body. Increased amounts of many phenolic
compounds (lignans, flavonoids, phenolic acids) were in-
deed detected in both the green parts and the seeds of
W92 flax plants [13]. As a control, the level of phenolic







Anthocyanins 0.004 ± 0.000 0.013 ± 0.001 0.006
Proanthocyanidin 0.021 ± 0.002 0.037 ± 0.003 0.02
Secoisolariciresinol diglucoside
(SDG)
12.112 ± 0.03 39.785 ± 0.0 0.005
Ferulic acid 0.57 ± 0.029 1.16 ± 0.035 0.01
Ferulic acid glucoside 1,488 ± 0.041 2.14 ± 0.053 0.02
Coumaric acid 0.340 ± 0.019 0.368 ± 0.016 0.04
Coumaric acid glucoside 1.006 ± 0.030 1.721 ± 0.032 0.006
Caffeic acid 0.006 ± 0.000 0.011 ± 0.001 0.06
Caffeic acid glucoside 0.636 ± 0.009 1.336 ± 0.007 0.01
p-Hydroxybenzoic acid 0.004 ± 0.001 0.011 ± 0.001 0.06
Flavonols 0.013 ± 0.001 0.022 ± 0.001 0.005
Vanillin <0.001 <0.001
Acetovanillone <0.001 <0.001
The results are the mean values ± SD (n = 6).Biochemical analysis of seedcakes and fibers from wild
type and W92 plants
First, we identified the plant product that is most suit-
able for the isolation of antimicrobial compounds. There
are two main products that are obtained from flax:
seeds, the source of oil and seedcake, which is the ma-
terial remaining after oil pressing; and fiber, which is
derived from the plant stem. A detailed analysis of the
phenylpropanoid contents in these products from con-
trol and transgenic plants is presented in Table 2. The
comparison of phenylpropanoids content firstly revealed
much higher amounts of these compounds in the seed-
cakes than in the fiber and secondly higher level of this
compounds in raw products from genetically modified
plants in comparison to control.
The total phenolic contents in seedcakes from trans-
genic W92 plants (46,6 mg/gFW) is significantly higher
when in control- unmodified plants (16,2 mg/gFW).
Secoisolariciresinol diglucoside (SDG) is the main phenyl-
propanoid compound identified in seedcakes, and its con-
tent −12,1 mg/g FW for control and 39.78 mg/g FW for
W92plants is respectively about75% and 85% of the total
phenolic content. The UPLC analysis also revealed the
presence of SDG in the fibers but a much lower quantity
(1.05 mg/gFW for transgenic plants). Other compounds
with antioxidant, anti-inflammatory and antibacterial pro-
perties were also analyzed. Flavonols (kaempferol and
quercetin), anthocyanins and proanthocyanidins were only
detected and analyzed in the seeds and seedcakes; they
were not detected in the fibers. We detected phenolic













1.056 ± 0.05 0.01
0.082 ±
0.05
0,350 ± 0.08 0.002
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were ferulic acid, p-coumaric acid and caffeic acid and
their glycoside derivatives [13]. Ferulic acid is also the
most common phenolic acid in the fiber. However, the
content of phenolic acids in the fibers was much lower
than in the seedcakes. The compounds that were only
identified in the fibers were vanillin and acetovanillone.
The general conclusion that might be drawn from the
data is that seedcakes are the richest source of phenyl-
propanoid compounds in the plant and the level of this
compounds in modified flax plants is significantly higher
than in control plants. Therefore, for further experi-
ments, we used seedcakes as a source of antimicrobial
compounds.
Preparation of seedcake extract and study of
antimicrobial activities on standard (reference)
pathogenic bacterial strains
The seedcake extracts from control-wild type (WT) and
W92 plants were prepared (dry material) as described in
Methods. The content of particular constituents was veri-
fied by UPLC analysis and proportion between active
compound are similar to observed while row seedcakes
analysis (data not shown). Finally, dry extracts were dis-
solved in water to a final concentration (w/v) of 50, 30 and
10 mg/ml. The antioxidant and antibacterial properties of
such obtained preparation were analysed, in a purpose, to
find the best source to generate antimicrobial preparation
based on flax. All preparation were analysed to measure
total phenolic content (as was expected the highest in
preparation from W92 plants) and antioxidant potential
(W92 plants preparation indicate almost three time better
antioxidant properties – lower IC-50 parameter than
unmodified plants preparation). Finally the antimicro-
bial activity of seedcake preparations were tested on
reference (usually used for antibiotics testing) bacter-
ial strains. The low concentration of seedcake pre-
paration from control plants do not show any
antibacterial properties, only preparation 50 mg/mlTable 3 The total phenolic content, antioxidant potential of d
modified flax plants and effect on reference bacterial strains
WT seedcakes dried extract
50 mgDW/ml preparation 50 mgDW
Total phenolics content [mg/ml] 24.26 ± 0.03 31
IC-50 [μl]* 27.5 ± 0.04 10
K. pneumoniae ATCC 700603** 64% ± 3.03 10
S. aureus ATCC 29213** 52% ± 2.01 10
P. aeruginosa ATCC 27853** 46% ± 3.50 10
E. coli ATCC 25922** 75% ± 1.89 10
The antimicrobial activity of seedcake preparations were tested on reference bacter
(10 mg/ml and 30 mg/ml) do not show any antibacterial properties (data not show
*The antioxidant potential (IC50) was defined as the amount (μl) of preparation tha
inhibition rate compared to the untreated bacteria (% of growth inhibition) after 6indicate such properties (see Table 3) but this activity
was predominantly lower (except E. coli ) then ob-
served for five time lower concentration of W92
based preparation. The comparable (50 mg/ml) con-
centration made from transgenic plant seedcakes kills
all tested bacteria. As well lower (30 mg/ml) concen-
tration of seedcake preparation based on W92 plants
indicates high bactericidal activity reduction of bacter-
ial from 87% to 100%. The obtained results to allow
us to claim that seedcakes from W92 plants are the
best source for antimicrobial preparation creation.
Antioxidant properties of seedcake extract
The process of microbial infection is usually started by
oxygen free radical synthesis. Therefore, addition of exter-
nal antioxidants might be helpful in arrest bacterial
growth. Therefore, the antioxidant potential of the seed-
cake extract was measured using a chemiluminescence
method, as described elsewhere [22]. The antioxidant po-
tential was expressed as the IC50 value, which means the
amount of extract inhibiting the oxidation of luminol by
50%. The antioxidant properties of the seedcake prepar-
ation were compared to those of well-known water-soluble
antioxidants (ascorbic acid, chlorogenic acid, caffeic acid)
and SDG standard solutions. The data are presented in
Figure 1. It was found that the preparation made from
seedcakes exhibits very high antioxidant potential: 13.5-
fold higher than ascorbic acid and more than 4-fold higher
than SDG. However, it was lower than that of the strong
antioxidants caffeic acid (4-fold lower) and chlorogenic
acid (6-fold lower). The very high antioxidative status of
the preparation suggests that it may have great biomedical
potential not only as an antimicrobial but also as an anti-
inflammatory agent.
Antimicrobial properties of seedcake preparations
Next, the antimicrobial properties of seedcake extract on
clinical strains of pathogenic bacteria were investigated.
Three different concentrations of W92 flax seedcakeried seedcake extract preparation from wild type and
W92 seedcakes dried extract
/ml preparation 30 mgDW/ml preparation 10 mg/ml preparation
.59 ± 0.05 18.45 ± 0.03 6.03 ± 0.06
.56 ± 0.03 18.15 ± 0.03 26.36 ± 0.04
0% ± 0.00 98% ± 0.01 72% ± 0.93
0% ± 0.01 93% ± 1.03 60% ± 0.63
0% ± 0.00 100% ± 0.02 85% ± 1.05
0% ± 0.23 87% ± 1.83 48% ± 1.82
ial strains. The low concentration of seedcake preparation from control plants
n).
t inhibits luminol chemiluminescence by 50%. **The presented results are the
h treatment. The results are the mean values ± SD (n = 5).
Figure 1 The antioxidant activities of seedcake extract and equimolar contents of standard antioxidants. The antioxidant activity was
indicated as the IC-50 parameter. The results are the mean values ± SD (n = 6). The results are statistically significant (P < 0.05).
Table 4 Antibiotic resistance characteristics and MIC values of seedcake extracts tested on Gram-negative
bacterial strains
Bacterial strains Strain characteristics MIC values
(mg/mL)
Bacterial strains Strain characteristics MIC values
(mg/mL)
K. pneumoniae ATCC 700603 reference strain 30 P. aeruginosa ATCC 27853 reference strain 30
K. pneumoniae 38 MDR; ESBL+ 30 P. aeruginosa 9/5 MDR 10
K. pneumoniae 36 MDR; ESBL+ 50 P. aeruginosa 12/3 MDR 10
K. pneumoniae 31 MDR; ESBL+ 50 P. aeruginosa 14/3 MDR; carbapenemase+ 10
K. pneumoniae 44 MDR; ESBL+ 30 P. aeruginosa 15/3 MDR 10
K. pneumoniae 43 MDR; ESBL+ 50 P. aeruginosa 49/3 S 30
K. pneumoniae 46 S 50 P. aeruginosa 82/3 MDR 30
K. pneumoniae 37 S 30 P. aeruginosa 113 MDR; carbapenemase+ 30
K. pneumoniae 35 S 50 P. aeruginosa 249/P MDR 30
K. pneumoniae 34 S 50 P. aeruginosa 3 MDR 30
K. pneumoniae 33 S 30 P. aeruginosa 12 MDR 30
E. coli ATCC 25922 reference strain 50 P. aeruginosa 14 MDR 30
E. coli 1426 S 50 P. aeruginosa 18 MDR 10
E. coli 1419 S 30 P. aeruginosa 20 MDR 10
E. coli 1417 S 30 P. aeruginosa 164 MDR 30
E. coli 1416 S 30 P. aeruginosa 0013 S 30
E. coli 1387 S 30 P. aeruginosa 0038 MDR 30
E. coli 1378 S 30
E. coli 1303 S 50
E. coli 1261 S 30
E. coli 1288 S 50
E. coli 1273 S 50
The MIC tests were performed by a broth microdilution method according to the European Committee on Antimicrobial Susceptibility Testing standards (EUCAST,
www.eucast.org). was estimated by three independed biological repetition.
MDR – acquired resistance to more than 3 groups of antibiotics; ESBL + − Extended-Spectrum Beta-Lactamases, S – sensitive, no acquired resistance.
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were prepared. The levels of particular active compounds
in all tested dilutions and dry extract were measured and
presented in Table 1. The content of phenolic acids, SDG
and other compounds are proportional to values observed
while row seedcake analysis and proportion of the particu-
lar compound do not change after freeze drying and dilu-
tion process. Therefore, such method of active solution
preparation obtaining procedure can be used also in the
future without fears of biological activity of achieved
preparations.
The MIC values for control and clinical bacterial strains
exposed to the seedcake preparations are presented in
Tables 4 and 5. From the data obtained, it is clear that
Gram-negative bacteria are more susceptible to the seed-
cake extract than the Gram-positive bacteria. K. pneumo-
niae and E. coli strains were inhibited by the 30 and
50 mg/ml concentrations of the extract. The lowest MIC
values at the concentrations of 10 mg/ml and 30 mg/ml
were noted for the P. aeruginosa strains regardless of the
multidrug resistance feature of the clinical strains. Clinical
Gram-positive isolates were less susceptible to the antibac-
terial activity of seedcake extract. The MIC was 50 mg/ml
for clinical staphylococci and higher for clinical entero-
cocci. To identify the bacteriostatic or bactericidal activityTable 5 Antibiotic resistance characteristics and MIC
values of seedcake extracts tested on Gram-positive
bacterial strains
Bacterial strains Strain characteristics MIC value [mg/mL]
S. aureus ATCC 29213 Reference strain 50
S. aureus 1 S 50
S. aureus 2 S 50
S. aureus 3 S >50
S. aureus 4 S 50
S. aureus 5 S 50
S. epidermidis1MRS MRS 30
S. epidermidis2MRS MRS 50
S. epidermidis 3MRS MRS 50
S. epidermidis 4 S 50
S. epidermidis5MRS MRS >50
E. faecalis 1 S >50
E. faecalis 2 S >50
E. faecalis 3 S >50
E. faecalis 4 S >50
E. faecalis 5 S >50
The MIC tests were performed by a broth microdilution method according to
the European Committee on Antimicrobial Susceptibility Testing standards
(EUCAST, www.eucast.org). was estimated by three independed
biological repetition.
S – sensitive, no acquired resistance. MRS –methicillin-resistant staphylococci.
The results are the mean values ± SD (n = 3). All results are statistically
significant (P < 0.05).of seedcake extracts, killing curves for the reference strains
were determined (Figure 2). In each analyzed case, an ex-
tract concentration of 10 mg/ml was insufficient to obtain
an inhibitory or killing effect against the tested strains,
and the growth parameters of the bacterial cultures under
such conditions were similar to those of the control. For
P. aeruginosa ATCC 27853 cultures, the extract concen-
tration of 30 mg/ml inhibit bacterial growth, and after
24 hours of incubation, a cfu level equal to the initial one
was detected (Figure 2A). Other bacterial cultures exposed
to the same extract concentration exhibited an increase in
cell number of one order of magnitude for E. coli ATCC
11229 and S. aureus ATCC6538, or two orders of magni-
tude for K. pneumoniae ATCC 700603 after 24 hours of
incubation (Figure 2B-D). The 30 mg/ml concentration of
seedcake extract was identified as bacteriostatic for all
of the reference strains used for growth curve.
Gram-negative reference strains were much more sus-
ceptible to the highest concentration of extract, which
reduced the bacterial count by around 3 orders of magni-
tude for K. pneumoniae to 5 for E.coli and 6 for P. aerugi-
nosa. The P. aeruginosa cells appeared to be very sensitive
to the bactericidal activity of seedcake extract compounds,
because after 8 hours of incubation, the cfu/ml dropped
from 106 to 102 and after one day of incubation, no living
cell was detected in the culture (Figure 2A). The data sug-
gest that the seedcake extract obtained from the trans-
genic flax plants is a suitable candidate for antimicrobial
action with broad spectrum and partial selectivity.
Antimicrobial effect of standard substances
In order to verify which of the identified compounds in
the seedcake extract have the greatest impact on its anti-
bacterial action, we examined the effects on the reference
strain S. aureus ATCC 6538 of the pure compounds that
had been identified in the extract. In the experiment, the
concentrations of pure compounds were close to the used
concentrations of seedcake extract (sum of aglicons and
glicosylated form of phenolic acids) and, with a concentra-
tion 1 or 2 mg/ml of the standard substances correspond-
ing to 30 or 50 mg/ml of the seedcake preparation,
respectively. The higher concentration of 10 mg/ml was
also applied. The inhibition rate (% of growth inhibition)
compared to the untreated control bacteria was measured.
In addition, the inhibitory effect of the seedcake prepara-
tions used in earlier experiments with clinical strains was
assessed. The data suggest that p-coumaric and ferulic
acid make a considerable contribution to the antimicrobial
properties of the seedcake extract. In the case of p-couma-
ric acid, 66.22% growth inhibition was observed at a con-
centration equal to the sum of its free form and its
glycoside derivative in the preparation of 50 mg/ml. For
ferulic acid, the growth inhibition rate was 63.5% for the
same concentration level. A significantly lower inhibitory
Figure 2 The antibacterial activity of seedcake extract on pathogenic bacteria. Growth curves of: Pseudomonas aeruginosa ATCC 27853,
Klebsiella pneumoniae ATCC 700603, Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213 strains exposed to seedcake extract
(preparation in a concentration of 10 mg/ml, 30 mg/ml and 50 mg/ml). The results are the mean values ± SD (n = 3). The results are statistically
significant (P < 0.05).
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(Table 6). It is proposed that to reach the antimicrobial ef-
fect of caffeic acid much higher concentrations need to be
used than are present in the tested seedcake extracts, as
indicated by the effect of the 10 mg/ml concentration. To
find out if the antimicrobial effect of phenolic acids derives
from the sum or synergy of their performance, simul-
taneous bacterial treatment of different combinations of
mixed standard substances was performed. In all of the
test situations, the results are significantly higher for the
simultaneous effect of two, three or four substancesTable 6 The effect of pure compounds and seedcake extract on
Compounds 1 mg/ml of e
p-coumaric acid 43.73% ± 0
Ferulic acid 29.99% ± 0
Caffeic acid 14.74% ± 0
SDG 4.94% ± 0.
p-coumaric and ferulic acid 92.59% ± 2
p-coumaric, ferulic and caffeic acids 100% ± 0.
SDG and ferulic acid. 30.35% ± 1
SDG, p-coumaric , ferulic and caffeic acids 100% ± 0.
Seedcake extract 83.24% ± 1.
The presented results are the inhibition rate compared to the control (% of growth
#30 mg/ml of extract contains 0.86 mg, 1.45 mg and 1.14 mg of p-coumaric, ferulic
dry extract, ##50 mg/ml of extract.than for a single component, and also higher than math-
ematical sum of the inhibitory effects observed for stand-
ard substances used in combination. Therefore, we
suggest that the tested compounds exhibit a synergistic ef-
fect. The results observed for a single SDG addition and
for mixtures including SDG shown that SDG has little or
no influence on the antimicrobial properties of seedcake
preparations. The efficacy of the seedcake extract and
p-coumaric and ferulic acid were compared to the activity
of ampicillin and gentamicin, which are respectively
the inhibitors of peptidoglycan and protein synthesisthe growth of Staphylococcus aureus ATCC 29213 cultures
ach 2 mg/ml 10 mg/ml
.2 66.22% ± 0.62 78.31% ± 1.2
.6 63.56% ± 0,89 78.31% ± 1.2
.5 17.82% ± 0,78 83.15% ± 1.2
9 5.32% ± 1.0 7.41% ± 0.6
.3 100% ± 0.91 100% ± 0.0
6 100% ± 0.0 100% ± 0.0
.3 63.99% ± 0.92 82.51% ± 1.6
0 100% ± 0.0 100% ± 0.0
8# 100% ± 0.2##
inhibition). The results are the mean values ± SD (n = 5).
and caffeic acids, respectively, and 5.5 mg SDG, which is equal to 10 mg of





Figure 3 Pulsed-field electrophoresis of seedcake treated
Escherichia coli. A. Line M1- MidRange Marker; line1-control
(untreated bacteria); lane 2- bacteria incubated with 10 mg/ml dried
seedcake extract; lane 3- bacteria incubated with 15 mg/ml dried
seedcake extract; lane 4- bacteria incubated with 40 mg/ml dried
seedcake extract; Lane M2- LowRange Marker. White arrow indicates
ca. 50 kb, a size of typical apoptotic domain. B. Correlation between
CFU number and seedcake extract concentration.
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turned out to be weakly susceptible top-coumaric and feru-
lic acids regardless of the antibiotic susceptibility profiles,
so their highest concentrations (>0.25and >0.80 mg/ml, re-
spectively) had no inhibitory effect on microbial growth.
Ampicillin was efficient at 0.002 mg/ml. Staphylococci ex-
hibited a high MIC level with phenolic acids but for several
strains, a similar or even lower level than for ampicillin
(0.25 mg/ml versus >0.51 mg/ml). p-coumaric acid was ac-
tive against S.epidermidis MRS isolates at an equal concen-
tration to gentamicin. The E.coli strains are antibiotic-
susceptible bacteria, and the MICs of the phenolic acids
were even 100 times higher than those for ampicillin and
gentamicin for most of the tested cultures. K. pneumoniae
isolates showed similar MICs for phenolic acids versus
ampicillin. The flax compounds had the strongest impact
on Pseudomonas growth. The ampicillin inhibitory concen-
tration was over 10 times higher than of p-coumaric acid
and similar to ferulic acid. For gentamicin-resistant Pseudo-
monas isolates, p-coumaric acid was 2–5 times more effect-
ive than the drug.
Potential mechanism of antimicrobial activity of seedcake
extracts
In order to investigate the mechanism of flax phenolics ac-
tion on bacterial cells we analysed the integrity of bacterial
genomic DNA upon cell treatment with seedcake extract
by pulse-field electrophoresis (Figure 3). Results demon-
strated, that bacterial DNA was visibly degraded after ex-
tract treatment but typical pattern of apoptosis (occurrence
of 50 kb or 500 kb domain) was not recorded. The lower
than 5 kb products of genomic DNA degradation can be
observed especially after treatment with 50 mg/ml dried
seedcake extract. Nucleolytic activity however remained un-
changed (data not shown). The in.vitro test on inpact of flax
seedcake extract on bacterial topoisomerase II (gyrase) ac-
tivity was performed (Figure 4). Samples treated with W92
seedcake extract showed partial (10 and 30 mg/ml) or total
(50 and 75 mg/ml) inhibition of gyrase activity (Figure 4A).
The similar experiment using dried seedcake extract from
control plants was also preformed (Figure 4B) –the slight
inhibition of gyrase activity was observed only after using
the highest concentration of extract (50 mg/ml). The data
presented in Figures 3 and 4 suggest that phenolics cause
bacteria DNA disintegration and inhibits gyrase activity.
Thus to the known effect of phenolics on bacteria cell
membrane we may add new targets of their action and
these are gyrase activity and genomic DNA disintegration.
Evaluation of skin irritation caused by W92 seedcake
preparations
To better assess the application potential of W92 seed-
cake preparations, the skin irritation test was performed
with use of EpiDerm, a three-dimensional human skinmodel. This is a fully developed epidermis with a func-
tional stratum corneum, (with keratinocytes in various
stages of differentiation). It is commonly used to valu-
ation the irritation potential of substances applied on
the skin. This test can be applied as an alternative for
evaluating dermal irritation prior to clinical tests. The
W92 seedcake preparations were directly applied to the
AB
1 32 4 5 6 7
8 10 119
Figure 4 Gyrase activity assay after treatment of seedcake extract. Part A. Analysis of W92 seedcake extracts activity. Lane 1- negative
control (without gyrase and extract); lane2- positive control (gyrase, without extract); lane 3- total inhibition control (novobiocin 25 μg/ml, gyrase,
without extract); lane 4- reaction mixture with 10 mg/ml dried seedcake extract; lane 5- reaction mixture with 30 mg/ml dried seedcake extract;
lane 6- reaction mixture with 50 mg/ml dried seedcake extract; lane 7- reaction mixture with 75 mg/ml dried seedcake extract. Part B. Analysis of
control plant seedcake extracts activity. lane 8- positive control (gyrase, without extract), lane 9- reaction mixture with 10 mg/ml dried seedcake
extract; lane 10- reaction mixture with 30 mg/ml dried seedcake extract; lane 11- reaction mixture with 50 mg/ml dried seedcake extract.
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culture. The in vitro skin irritation evaluation was ana-
lysed 2, 5 and 18 h after application of the preparations.
All analysed preparations doesn’t indicate any irritating
effects on the human skin model (Figure 5). The cell via-
bility after the application of all seedcake preparation
was between 94% to 104,6% after 2, 5 and 18 h treat-
ment. As a positive control the 1% Triton X-100 was
used –this solution indicate moderate irritation effect
and cell viability varied between 34,8% to 25,4% depend-
ing on time of treatment. Obtained results prove that
analysed preparations appeared to be safe for dermato-
logical applications.
Discussion
Recently, many studies have focused on identifying po-
tential antimicrobial agents from natural resources. The
antimicrobial activity of plant extracts has been known
for many years, as plants are known to produce useful
antimicrobial phytochemicals [23]. Therefore, it is rea-
sonable to try to identify a plant type that is a renewable
source and provides sufficient amounts of these com-
pounds. Plants with a certain tradition in their cultiva-
tion and with levels of antimicrobial compounds that
can be increased by genetic engineering could be a suffi-
cient source of antimicrobial preparations. Previously, aflax plant was transformed with three genes containing
the cDNAs coding for key enzymes of the flavonoid bio-
synthesis pathway. This transgenic plant was analyzed to
reveal the accumulation of flavonols and other phenolic
compounds with potential antimicrobial activity. It was
previously shown that the metabolite content of W92
plants, similarly to unmodified plants, varied by less than
10% from a year to year and that the stoichiometry be-
tween individual metabolites does not change either
[24]. Therefore, these plants can be used as a stable
source for the production of biotechnological prepara-
tions In this study, we analyzed the phenolic compound
contents in extracts from seeds; seedcakes and fibers in
more detail, and assessed their impact on pathogenic
bacterial growth. Flavonoids are known to possess anti-
fungal, antiviral and antibacterial activity. Moreover, sev-
eral groups of flavonoids have demonstrated synergy in
action within their groups and with existing chemother-
apeutics [25]. It is thus hypothesized that transgenic
plants overproducing flavonoids might prove to be a
suitable source of antimicrobial compounds.
The seedcake extracts from the transgenic flax possess a
unique composition of natural antioxidants [13]. Besides
the presence of SDG, there are phenolic acids, such as
ferulic, p-coumaric and caffeic acids and their glycosyl de-
























50mg/ml 1% Triton X-100
Figure 5 Skin irritation potential of seedcake preparations on reconstructed Human epidermal model EpiDerm. The irritation potential
was determined for preparations 10 mg/ml, 30 mg/ml,50 mg/ml and 1% Triton X-100 as a positive control after 2, 5 and 18 h of treatment. The
experiment was performed in duplicate.
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crobial agents against a wide range of microorganisms. In-
vestigations into the mechanism of action of flavonoids
revealed that they have multiple cellular targets rather
than one specific site of action. E.coli cells treated with
phenolics or anthocyanins exhibited local disintegration
and irregularity in their outer membrane and leakage of
cytoplasm [26]. Phenolics has the unique ability to per-
form redox reactions at the plasma membrane and se-
quester electrons from the respiratory processes. The
partial hydrophobicity of phenolics enables them to bind
to the outer membrane and to change the membrane flu-
idity. The irregularity in cell shape supports the theory of
localized chemical interactions at the cell surface. Once
the membrane has been penetrated, smaller phenolic
compounds can enter the cell and disrupt its metabolism.
It is reported that the partial lipophilic nature of phenolic
acids enables them to cross the cell membrane by passive
diffusion in their undissociated form, and consequently
disturb the cell membrane structure [27]. They cause acid-
ification of the cytoplasm, protein denaturation, and pos-
sibly also cell death [28]. It is also suggested that pH and
the length of the alkyl chain determine the antimicrobial
effect of phenolic acids [28].
The data obtained strongly suggest that mainly the
phenolic acids are the most effective compounds in anti-
microbial activity of seedcake extract. Although the
exact mechanism of this action is as yet unknown, there
are several suggestions in the literature on how phenyl-
propanoids compounds might affect bacteria growth. It
is pointed out that the mechanism of action of phenolicsrevealed that they have multiple cellular targets rather
than one specific site of action. Phenolics bind to the
outer membrane and change the membrane fluidity
which might results in the local disintegration of bacter-
ial cell membrane and cytoplasm leakage [26,27]. They
might cause acidification of the cytoplasm, protein de-
naturation, and possibly also cell death [28].
Detailed analysis of the impact of flax seedcake extract
on bacteria cell revealed new targets of extract compo-
nent action and these are genomic DNA and key enzyme
involved in DNA replication. Treatment of bacteria cells
with seedcake extract exhibit DNA disintegration and
topoisomerase II (gyrase) inhibition. It is well known
that bacterial gyrase is the target of several antibiotics or
over antimicrobial agents that inhibit enzyme activity
[29,30]. For example novobiocin blocks the binding of
ATP to gyrase while nalidixic acid interferes with the
breakage and resealing of DNA chains. It is thus sug-
gested that seedcake extract might be used as alternative
antibiotic to treat multibacterial infections.
We suggest that the structural diversity within plant
phenolic compounds resulted in their impact on the
growth of a broad spectrum of bacterial strains. Accord-
ing to experiments that included an assessment of the
antibacterial activity of propolis, mixtures of phenolic
compounds are effective against many bacterial strains
[31]. This is perhaps also the reason why the mixture of
phenolic acids and lignans in GM flax extract has far
more effective antibacterial activity than a pure single
compound. The suggestion is further supported by the
result from the experiment described in this paper where
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The results suggest that the activity of an individual
component changed in the presence of other com-
pounds in the extracts [32,33]. The synergy in action of
extract components might explain the high antimicrobial
activity of the seedcake preparation.
The analysis of influence of W92 seedcake extract on a
three-dimensional human skin model (EpiDerm), which is
acommonly used to assess the irritation potential of der-
mally applied substances, indicate no irritation effect of
tested preparation. This test can be applied as an alterna-
tive for evaluating dermal irritation prior to clinical tests.
Our results show that these preparations are safe for use
on the skin that we suggest that seedcake preparations
might be a good candidate for treatment of bacterial in-
fected human skin (for example acne) and an alternative
to antibiotic therapy of infected wounds. The use of such
preparation for human therapy (especially for injection)
should be certainly preceded by clinical tests.
Conclusion
The results of this study on genetically modified flax
plants resulted in a potential new, pharmaceutical product
containing biologically active compounds that exhibit anti-
bacterial properties. Moreover, the natural products would
be present in favorable proportions to counter bacterial in-
fection according to the data. It should be pointed out that
both the composition and component concentration of
the product might be easily modified to give better specifi-
city against different bacterial strains.
In this particular study, the seedcake extract was tested
against sensitive and multidrug-resistant clinical bacter-
ial strains. The obtained data are comparable to the in-
hibitory effect of the reference strains commonly used in
antibiotic testing. The results showing the similar anti-
bacterial activity of the flax seedcake preparation against
different strains in a group of one species suggest a non-
specific mode of action on bacterial cells. An interesting
aspect of seedcake antibacterial activity is the bacteri-
cidal efficiency, which was highest against P. aeruginosa
among all the tested bacteria. These bacteria are known
to be the most important nosocomial pathogens that de-
velop various mechanisms of resistance to antibiotics
and antiseptic chemical compounds. It should be em-
phasized that these strains were isolated from severe in-
fections where the therapy options were very limited.
The presumed mechanism of seedcake extracts action
may be related to interactions between the extract com-
ponent and the bacterial membrane because Gram-
negative strains exhibited higher susceptibility to this
preparation. Gram-positive strains were more resistant
than Gram-negatives, but at higher concentrations, the
seedcake extracts still inhibited the growth of staphylo-
cocci and enterococci. The results of the treatment of thedrug-resistant clinical bacterial strains indicate the great
application potential of seedcake flax preparations. There-
fore, we suggest that flax-derived natural products are a
promising alternative to antibiotic therapy. Moreover, our
results show that these preparations are safe for use on
the skin. Such new application possibilities of flax and es-
pecially their biomedical relevance can contribute to the
renewal of flax cultivation worldwide.
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